Hancock jaffe laboratories, inc. (HJLI)
CashFlow / Yearly
Dec'19Dec'18Dec'17
Cash Flows from Operating Activities
Net Loss

-7,625

-13,042

-7,791

Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount

-

6,562

1,710

Gain on extinguishment of convertible notes payable

-

1,481

257

Stock-based compensation

941

1,922

878

Depreciation and amortization

123

133

139

Amortization of right-of-use assets

273

-

-

Change in fair value of derivative liabilities

-

191

-26

Loss on impairment of intangible asset

588

319

-

Changes in operating assets and liabilities:
Accounts receivable

-32

-3

11

Inventory

-

-

-90

Prepaid expenses and other current assets

52

6

11

Security deposit and other assets

-

-0

-0

Accounts payable

144

-294

545

Accrued expenses

-56

-210

377

Deferred revenue - related party

-

-

103

Deferred revenues

-

-70

-

Payments on lease liabilities

265

-

-

Total adjustments

1,728

6,686

3,589

Net Cash Used in Operating Activities

-5,896

-6,355

-4,202

Cash Flows from Investing Activities
Collection of receivable for sale of assets

-

-

166

Issuance of note receivable to related party

-

-

160

Receipts from collections of note receivable to related party

-

-

160

Advances to related party

-

-

206

Receipts from repayment of related party advances

-

-

216

Purchase of property and equipment

363

12

10

Net Cash Used in Investing Activities

-363

-12

165

Cash Flows from Financing Activities
Proceeds from private placement, net

2,317

-

-

Proceeds from public offering, net

3,319

-

-

Proceeds from initial public offering, net

-

7,657

-

Initial public offering costs paid in cash

-

706

209

Repayments of notes payable

-

1,125

-

Proceeds from issuance of note payable to related party

-

-

311

Repayments of notes payable - related party

-

120

174

Proceeds from issuance of notes payable, net

-

722

275

Proceeds from issuance of convertible notes, net

-

2,603

2,564

Proceeds from issuance of redeemable Series B preferred stock and warrant, net

-

-

1,292

Net Cash Provided by Financing Activities

5,636

9,031

4,058

Net Increase (Decrease) in Cash, Cash Equivalent, and Restricted Cash

-623

2,662

-

Net Increase in Cash, Cash Equivalent, and Restricted Cash

-

-

21

Supplemental Disclosures of Cash Flow Information:
Cash Paid During the Period For: Interest paid

0

286

105

Non-Cash Investing and Financing Activities
Conversion of convertible note payable - related party and accrued interest into common stock

-

517

-

Exchange of note payable - related party and accrued interest into common stock

-

150

1

Fair value of placement agent warrants issued in connection with preferred stock offering included in derivative liabilities

-

-

57

Fair value of warrants issued in connection with convertible debt included in derivative liabilities

-

1,046

870

Embedded conversion option in convertible debt included in derivative liabilities

-

1,239

2,349

Derivative liabilities reclassified to equity

-

6,059

-

Conversion of convertible notes payable and accrued interest into common stock

-

5,743

-

Conversion of preferred stock into common stock

-

5,170

-